GlassScriptPhysician profile
Ramesh Parchuri
NPI 1437224300
$11,349.22
in general payments reported to CMS, 2019-2025
40 companies · $1,238 in 2025
The $1,238 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,631 · 2020: $1,701 · 2021: $1,884 · 2022: $1,613 · 2023: $1,309 · 2024: $974 · 2025: $1,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,520.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,225.68 | 2019-2025 | Xarelto, Invega Sustenna |
| Glaxosmithkline, LLC. | $1,356.93 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,256.05 | 2019-2025 | Jardiance, Spiriva, Synjardy |
| Astrazeneca Pharmaceuticals LP | $970.53 | 2019-2025 | Farxiga, Lokelma, Airsupra |
| Novartis Pharmaceuticals Corporation | $523.23 | 2020-2025 | |
| Astellas Pharma US INC | $505.75 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $460.62 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $341.73 | 2020-2025 | Caplyta |
| Amarin Pharma, INC. | $332.91 | 2019-2023 | |
| Pfizer INC. | $309.49 | 2019-2020 | |
| Viiv Healthcare Company | $279.51 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $272.55 | 2019-2023 | Belsomra, Steglujan, Steglatro |
| Gilead Sciences, INC. | $260.61 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $249.57 | 2019-2024 | Rexulti |
| Biotronik INC. | $234.42 | 2019-2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Parchuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.